CH658858A5 - Acide azetidinyl sulfonique et analogues. - Google Patents

Acide azetidinyl sulfonique et analogues. Download PDF

Info

Publication number
CH658858A5
CH658858A5 CH5452/83A CH545283A CH658858A5 CH 658858 A5 CH658858 A5 CH 658858A5 CH 5452/83 A CH5452/83 A CH 5452/83A CH 545283 A CH545283 A CH 545283A CH 658858 A5 CH658858 A5 CH 658858A5
Authority
CH
Switzerland
Prior art keywords
amino
hydrogen
alkyl
salt
substituted
Prior art date
Application number
CH5452/83A
Other languages
English (en)
French (fr)
Inventor
William Allen Slusarchyk
David Roy Kronenthal
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH658858A5 publication Critical patent/CH658858A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH5452/83A 1982-10-06 1983-10-06 Acide azetidinyl sulfonique et analogues. CH658858A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43317582A 1982-10-06 1982-10-06

Publications (1)

Publication Number Publication Date
CH658858A5 true CH658858A5 (fr) 1986-12-15

Family

ID=23719123

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5452/83A CH658858A5 (fr) 1982-10-06 1983-10-06 Acide azetidinyl sulfonique et analogues.

Country Status (27)

Country Link
JP (1) JPS5988462A (enrdf_load_html_response)
KR (1) KR900005132B1 (enrdf_load_html_response)
AU (1) AU568312B2 (enrdf_load_html_response)
BE (1) BE897883A (enrdf_load_html_response)
CA (1) CA1253501A (enrdf_load_html_response)
CH (1) CH658858A5 (enrdf_load_html_response)
DD (1) DD222016A5 (enrdf_load_html_response)
DE (1) DE3336262A1 (enrdf_load_html_response)
DK (1) DK457983A (enrdf_load_html_response)
ES (1) ES526282A0 (enrdf_load_html_response)
FI (1) FI833631A7 (enrdf_load_html_response)
FR (1) FR2534253B1 (enrdf_load_html_response)
GB (1) GB2129428B (enrdf_load_html_response)
GR (1) GR79704B (enrdf_load_html_response)
HU (1) HU190507B (enrdf_load_html_response)
IE (1) IE56600B1 (enrdf_load_html_response)
IL (1) IL69917A (enrdf_load_html_response)
IT (1) IT1171722B (enrdf_load_html_response)
LU (1) LU85033A1 (enrdf_load_html_response)
NL (1) NL8303410A (enrdf_load_html_response)
NO (1) NO833626L (enrdf_load_html_response)
NZ (1) NZ205642A (enrdf_load_html_response)
PH (1) PH24175A (enrdf_load_html_response)
PT (1) PT77458B (enrdf_load_html_response)
SE (1) SE8305509L (enrdf_load_html_response)
SU (1) SU1318146A3 (enrdf_load_html_response)
ZA (1) ZA837491B (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
DE3588039T2 (de) * 1984-08-06 1995-11-16 Fujisawa Pharmaceutical Co Azetidinonderivate und Verfahren zu ihrer Herstellung.
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Also Published As

Publication number Publication date
FI833631A0 (fi) 1983-10-06
NZ205642A (en) 1986-08-08
KR900005132B1 (ko) 1990-07-20
NL8303410A (nl) 1984-05-01
ES8504814A1 (es) 1985-04-16
NO833626L (no) 1984-04-09
KR840006337A (ko) 1984-11-29
PH24175A (en) 1990-03-22
SU1318146A3 (ru) 1987-06-15
DE3336262A1 (de) 1984-04-12
FR2534253A1 (fr) 1984-04-13
IT1171722B (it) 1987-06-10
PT77458B (en) 1986-02-26
GR79704B (enrdf_load_html_response) 1984-10-31
IL69917A0 (en) 1984-01-31
ES526282A0 (es) 1985-04-16
SE8305509D0 (sv) 1983-10-06
DK457983A (da) 1984-04-07
IE832354L (en) 1984-04-06
GB8326626D0 (en) 1983-11-09
IE56600B1 (en) 1991-10-09
LU85033A1 (fr) 1984-05-10
ZA837491B (en) 1984-06-27
GB2129428B (en) 1986-03-19
IT8323172A0 (it) 1983-10-06
DD222016A5 (de) 1985-05-08
DK457983D0 (da) 1983-10-04
FR2534253B1 (fr) 1985-07-26
JPS5988462A (ja) 1984-05-22
FI833631A7 (fi) 1984-04-07
BE897883A (fr) 1984-03-30
PT77458A (en) 1983-11-01
CA1253501A (en) 1989-05-02
AU1993983A (en) 1984-04-12
IL69917A (en) 1987-10-20
AU568312B2 (en) 1987-12-24
GB2129428A (en) 1984-05-16
HU190507B (en) 1986-09-29
SE8305509L (sv) 1984-04-07

Similar Documents

Publication Publication Date Title
EP0051381B1 (en) O-sulfated beta-lactam hydroxamic acids
FR2531427A1 (fr) Composes d'azetidine a action therapeutique
KR890000418B1 (ko) 아제티딘 및 그의 제조방법
US4670553A (en) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
FR2547819A1 (fr) Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques
CH658858A5 (fr) Acide azetidinyl sulfonique et analogues.
CH654297A5 (fr) 2-oxo-azetidines.
FR2617483A1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)-carbonyl)azetidines a action therapeutique
FR2617482A1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)-carbonyl)azetidines a action therapeutique
US4889930A (en) Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
FR2550195A1 (fr) Acides (2-oxo-1-azetidinyloxy)-2-propenoiques a proprietes therapeutiques
FR2515178A1 (fr) Sels internes d'acides 2-oxo-1 azetidinesulfoniques, et leur procede de preparation
FR2533569A1 (fr) Ester 3-acylamino-2-oxo-1-azetidinyliques d'acides phosphoniques, de l'acide phosphorique et d'esters de l'acide phosphorique
FR2552757A1 (fr) Procede de production de bromoacenaphtylene condense
US5106977A (en) Intermediates for a process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl]azetidines
CA1268763A (en) 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
US4551276A (en) 2-Oxoazetidin-1-yloxymethyl sulfonic acid and analogs
US4980465A (en) Process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl)] azetidines and intermediates used therein
FR2551750A1 (fr) 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique
FR2554445A1 (fr) Acides 4-(3-acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoiques utiles notamment comme antibacteriens et medicaments les contenant
JPS59206381A (ja) 3−アシルアミノ−1−スルホニルアミノカルボニルメトキシ−2−アゼチジノン類
EP0135814A1 (en) 1-(1H-tetrazol-5-ylalkoxy)-2-azetidinones
JPS6094958A (ja) アゼチジノン類

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased